healthcare
Spex Capital launches EUR 100m early-stage healthtech fund
New GP has sights set on further impact vehicles such as food and climate technology
Seventure preps third generation of microbiome fund
Health for Life III to be slightly larger than EUR 250m predecessor; will invest in Europe, US, Israel
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
H2 turns to bilateral talks to get Optegra sale over the line, sources say
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
Novalpina fund exits Laboratoire XO to Stanley Capital
French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group
EQT closes new European tech growth-stage fund on EUR 2.2bn
Closed above target, the new vehicle has raised a total of EUR 2.4bn in commitments
Ampersand closes USD 1.2bn healthcare fund for US, EU deployment
Fundraise follows hiring push in Europe; GP typically deploys USD 10m-50m tickets in primary buyouts
SHS nears EUR 250m hard cap on sixth fund
Healthcare fund’s EUR 200m target exceeded in first close with commitments from around 60 LPs
Five Arrows exits pharmacy group Laf Sante to Latour
Vendor plans to reinvest in pharmacy chain; Bpifrance takes minority stake
Forbion exceeds Growth Opportunities II target with EUR 470m first close
Biopharma GP sees growing demand for private capital amid IPO lull; gears up for EUR 600m hard-cap by summer end
VC Profile: Jeito Capital in final stretch of biotech fund deployment
Founder Rafaèle Tordjman outlines the French sponsor’s strategy as it aims to remain independent amid wave of consolidation in healthcare funds
QPE backs MBO of Republic M!
The buyout of the British commercial services outsourcer is QPE's seventh platform deal under its maiden fund
Teachers' Venture Growth leads Alan's EUR 183m Series E
Temasek, Index, Coatue, Ribbit Capital, Exor, Dragoneer, and Lakestar also joined the round which values Alan at EUR 2.7bn
Astorg beats sponsors to acquire CordenPharma
The sponsor competed with Advent International in the final round of an auction led by William Blair
Cambridge Innovation Capital raises GBP 225m for Fund II
The VC firm's first closed-end fund will invest in Series A rounds of deep-tech and life science companies connected to Cambridge
GBL bags second healthcare asset this week with SBO of Sanoptis
Vendor Telemos to fully exit DACH eye clinics operator following auction that also saw ICG and Ares compete for the asset
GBL acquires Affidea from B-Flexion
Formerly known as Waypoint, vendor is fulling exiting the pan-European outpatient group; new owner will invest EUR 1bn in equity
Novo-backed ReViral acquired by Pfizer
The British biotech company is also backed by CR-CP, New Leaf, Andera Partners, and OrbiMed, among others
Specialist healthcare funds on track for another record year
GPs raised EUR 4.4bn with swelling need for healthcare investment but could face challenges in keeping a disciplined deployment
Jeito, INKEF, Forbion lead EUR 80m Series B for Precirix
Precirix last raised a EUR 37m Series A in 2018
Gilde Healthcare closes fourth buyout fund on EUR 517m
Double the size of its predecessor, the new vehicle was oversubscribed and saw nearly all Gilde’s existing LPs investing
Ufenau moves Corius and Altano to continuation fund
Bought in 2017, the dermatology and vet groups have been transferred into the Swiss GP’s third continuation vehicle
Queen's Park Equity backs Blue Ribbon MBO
The deal is the sixth from QPE's Equity Fund I
Limerston exits Prism to Charme
Charme will complete the deal through Charme IV, which has raised EUR 700m to date
Most read
